* Embecta Corp EMBC.OQ EMBC.O is expected to report
results on
August 15.
* The Wilmington Delaware-based company is expected to
report
revenue of $276.86 million, according to the estimate from one
analyst, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Embecta Corp is for
earnings of 87 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is "Sell".
* Wall Street's median 12-month price target for Embecta
Corp is
$29, below its last closing price of $30.00.
This summary was machine generated August 12 at 13:04 GMT. All
figures in US dollars unless otherwise stated